Overview Aging has a biology, and this biology drives age-related diseases (Geroscience). We at Einstein have demonstrated that the biology of aging can be targeted in experimental models to delay, stop, and in some examples, reverse manifestations of aging. Our overarching Mission is to make scientific discoveries in geroscience, leveraging on the expertise in our center in studying and targeting the pillars of aging, and to confirm their relevance of new findings to human aging through the unique Gero-human resource created in our center and to translate interventions proven relevant for human to drug discovery efforts. Centers of Excellence The institute for Aging Research is the home of two aging centers of international recognition. The Nathan Shock Center of Excellence, focused on the study of the biology of aging and the Einstein Paul F. Glenn Center solely dedicate to understanding the biology behind human Aging. Learn More Nathan Shock Center of Excellence LEARN MORE The Paul F. Glenn Center for Biology of Human Aging LEARN MORE Research Integrative Physiology Dietary strategies to delay aging Metabolism targeting to delay aging Cell autonomous and non-autonomous aging CNS control of metabolism and aging Cell Biology of Aging Proteostasis DNA repair Response to Stress Inflammaging Stem Cells Genetics of Aging Human Longevity Comparative genomics of longevity Translational Geroscience TAME Human Longevity Studies Clinical Geriatrics Training Einstein's Institute for Aging Research is committed to the development the next generation scientists in the biology of aging. Training programs are available for graduate and postdoctoral candidates. Learn More Multimedia 2nd Annual Longevity Studies Symposium More Videos Highlights Research Brief IGF-1 Hormone: Good for the Young but Bad for the Old Sep 24, 2021 Feature In Progress: Striving for Success Against Heart Failure Jun 29, 2021 News Release Experimental Drug Shows Potential Against Alzheimer's Disease Apr 22, 2021 See All Events More Events 30 September Sep Montefiore Einstein Health Tech Innovation Seminar - Digital Health Technologies Thu Sep 30 2021, 5:15 PM Speaker: Saya Nagori, MDFounding Physician, Simple Health (Series B raise in 2018). Founder, Fem Health. Founder and Practicing Glaucoma Surgeon, Vision MD Eye Doctors Speaker: Michael Docktor, MD.Co-Founder and CEO, Dock Health. Practicing Pediatric Gastroenterologist and Former Clinical Director of Innovation, Boston Children’s Hospital ZOOM, Virtual, Zoom Meeting sjariwal@montefiore.org More Dear all, I am excited to invite you to our Montefiore Einstein Health Tech Innovation Seminar. The topic will be Digital Health Technologies. Publications See More Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome.Heterochronic blood exchange attenuates age-related neuroinflammation and confers cognitive benefits: do microvascular protective effects play a role?Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction.Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.Chaperone-mediated autophagy sustains haematopoietic stem-cell function.ARDD 2020: from aging mechanisms to interventions.SCCNV: A Software Tool for Identifying Copy Number Variation From Single-Cell Whole-Genome Sequencing.The evolution of a tropical biodiversity hotspot.Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α.Common diseases alter the physiological age-related blood microRNA profile.